WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Danforth Advisors, LLC, today announced newly-established operations in the United Kingdom (UK) to support local life science companies with strategic advisory and management of corporate and clinical functions – scaling from initial company start-up through all phases of growth. The company’s integrated, stage-adjusted resources range from financing strategy, operational finance and accounting, human resources and strategic communications to operational and regulatory support for preclinical and clinical development.

Initially based in London, Danforth’s regional presence will extend to Cambridge and Oxford; covering the preeminent life sciences ecosystem known as the “golden triangle;” in addition to Northern England, Scotland and Bristol; where universities are increasingly fueling new company formation. Danforth’s UK operations will be led by Michael Cunniffe, Managing Director, who brings more than 20 years of experience to the role.

“This is a very exciting step in expanding our international reach, recognizing the number of companies emerging from world-class universities and research institutions in the UK and our ability to support their journey,” said Chris Connors, CEO of Danforth Advisors. “Particularly in today’s market, capital efficiency is critical, and we can help companies minimize fixed costs without compromising the integrity of their science or business operations – keeping their progress on track. We are thrilled to welcome Michael to lead our UK team and service to clients in the region.”

“I have long admired the unique role Danforth plays in helping life science companies scale and operate at their best. It’s a privilege to lead the company’s first overseas expansion,” said Cunniffe. “The UK has a proud history of pioneering novel medicines, and despite the challenging capital markets, we’ve seen many therapies advance and new companies established around novel technologies. I look forward to expanding Danforth’s UK team to serve a greater number of these companies, whether assisting with capital raising, managing day-to-day operations or de-risking expansion to the United States.”

Cunniffe is an accomplished life science CFO with experience in both the UK and US markets and across all stages of development, from discovery through commercialization. He has led numerous IPO and financing transactions and built and scaled infrastructure to enable commercial success. He holds a Masters in Finance degree from London Business School.

About Danforth Advisors

Danforth is the life science industry’s trusted partner for enterprise-wide managed functions, from corporate to clinical. The company’s variable, integrated capabilities include C-Level Advisory, Finance & Accounting, Human Resources, Strategic Communications, Risk Management, and Development Strategy & Operations. Founded in 2011, Danforth has been a strategic and operational partner to more than 1,000 life science companies, private and public, across all stages of the corporate life cycle. The company serves clients around the globe from its headquarters in Waltham, Massachusetts and regional bases in New York, Pennsylvania, California, and London. Additional information is available at www.danforthadvisors.com.

This item of content is a press release from a third party provider who make no warranties or representations in connection with this content and therefore PA can make no warranties in respect of its use.

Tags

More Like This

Chatham Financial Expands European Presence by Opening an Amsterdam Office

Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders

FORCYD announces expansion into Germany and appointment of new Partner as lead for the DACH region

Grath Expands Operations to The Middle East

Frazier & Deeter UK Relocates to London's Iconic Tower 42

Stax Opens New Central London Office Amidst Rapid U.K. Expansion

Boyden Sees Growth Across Europe, Welcoming New Partners in the East and the West

Builds Bio+ Announces London/UK Chapter to Boost Transatlantic Life Sciences Collaboration